tiprankstipranks
Trending News
More News >
Advertisement

SCDV - AI Analysis

Compare

Top Page

SCDV

Bahl & Gaynor Small Cap Dividend ETF (SCDV)

Rating:73Outperform
Price Target:
$28.00
The ETF SCDV has an overall rating that reflects a mix of strong financial performance across its holdings, tempered by valuation concerns and technical risks. Top contributors like Curtiss-Wright and Gildan Activewear drive the fund’s positive rating with robust earnings and strategic market positioning. However, weaker holdings such as Chemed and Enpro, which face valuation challenges and mixed earnings sentiment, slightly weigh down the overall score. The fund’s concentration in stocks with high P/E ratios and overvaluation risks is a notable factor investors should consider.
Positive Factors
Strong Top Holdings
Several of the largest positions, such as BWX Technologies and Curtiss-Wright, have delivered strong year-to-date performance, supporting the fund’s overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Industrials, Health Care, and Financials, reducing reliance on any single industry.
Consistent Performance
The ETF has shown steady gains over the year-to-date, one-month, and three-month periods, indicating solid momentum.
Negative Factors
High Expense Ratio
The ETF charges a relatively high expense ratio compared to other funds, which can eat into investor returns over time.
Over-Concentration in Industrials
Industrials make up over 32% of the portfolio, exposing the fund to risks if this sector faces challenges.
Limited Geographic Exposure
With over 94% of holdings in U.S. companies, the ETF lacks significant international diversification, making it vulnerable to domestic market fluctuations.

SCDV vs. SPDR S&P 500 ETF (SPY)

SCDV Summary

The Bahl & Gaynor Small Cap Dividend ETF (SCDV) focuses on small-cap companies in the U.S. and Canada that pay strong dividends. Small-cap companies are typically smaller, fast-growing businesses, and this ETF adds a unique twist by selecting those with a history of paying dividends, offering both growth potential and income. Some of its top holdings include The Ensign Group and Curtiss-Wright. This ETF might appeal to investors looking for diversification and a mix of growth and income. However, small-cap stocks can be more volatile than larger companies, meaning their prices can swing up and down more dramatically.
How much will it cost me?The expense ratio for the Bahl & Gaynor Small Cap Dividend ETF (SCDV) is 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on selecting small-cap stocks with strong dividend-paying capabilities. Active management typically involves higher costs due to the research and analysis required.
What would affect this ETF?The Bahl & Gaynor Small Cap Dividend ETF (SCDV) could benefit from economic growth and increased investor interest in small-cap stocks, particularly in sectors like Industrials and Health Care, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns may negatively impact small-cap companies, as they often face higher borrowing costs and are more sensitive to market volatility. Regulatory changes or sector-specific challenges in industries like Financials or Consumer Cyclical could also affect the ETF's performance.

SCDV Top 10 Holdings

The Bahl & Gaynor Small Cap Dividend ETF (SCDV) leans heavily on industrials and healthcare, with standout performers like BWX Technologies driving gains thanks to strong backlog growth and strategic acquisitions. Curtiss-Wright has also been steady, benefiting from robust financials despite valuation concerns. On the flip side, lagging names like Chemed and Tetra Tech have struggled with mixed earnings sentiment and sector-specific challenges, holding back the fund’s momentum. With its U.S.-focused portfolio and emphasis on dividend-paying small caps, SCDV offers a unique blend of growth and income, though its sector concentration adds a layer of risk.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
The Ensign Group7.58%$9.66M$10.54B17.11%
79
Outperform
Curtiss-Wright6.52%$8.31M$22.67B70.08%
77
Outperform
Gildan Activewear5.82%$7.41MC$12.53B24.54%
77
Outperform
Federal Signal5.46%$6.96M$7.89B53.05%
73
Outperform
BWX Technologies4.71%$6.00M$19.53B71.16%
71
Outperform
Evercore Partners4.10%$5.23M$11.29B10.34%
73
Outperform
Enpro3.96%$5.05M$4.79B53.58%
70
Outperform
Chemed3.94%$5.02M$6.78B-13.11%
71
Outperform
Victory Capital Holdings3.75%$4.78M$4.20B1.93%
76
Outperform
Tetra Tech3.52%$4.48M$8.37B-36.34%
69
Neutral

SCDV Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
24.73
Positive
100DMA
24.23
Positive
200DMA
23.19
Positive
Market Momentum
MACD
0.13
Negative
RSI
50.50
Neutral
STOCH
54.39
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCDV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 24.92, equal to the 50-day MA of 24.73, and equal to the 200-day MA of 23.19, indicating a neutral trend. The MACD of 0.13 indicates Negative momentum. The RSI at 50.50 is Neutral, neither overbought nor oversold. The STOCH value of 54.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SCDV.

SCDV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$127.46M0.70%
73
Outperform
$986.55M0.15%
74
Outperform
$660.17M0.79%
71
Outperform
$357.24M0.55%
69
Neutral
$253.43M0.30%
71
Outperform
$106.31M0.52%
70
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SCDV
Bahl & Gaynor Small Cap Dividend ETF
24.89
0.24
0.97%
SEIM
SEI Enhanced U.S. Large Cap Momentum Factor ETF
OSCV
Opus Small Cap Value ETF
SEIS
SEI Select Small Cap ETF
JSML
Janus Henderson Small Cap Growth Alpha ETF
SIXS
ETC 6 Meridian Small Cap Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement